Q4 2024 Streamline Health Solutions Inc Earnings Call
Speaker Change: [music].
Operator: Greetings.
Greetings and welcome to the streamline health solutions incorporated fourth quarter and fiscal year 2024 earnings Conference call. At this time all participants are in a listen only mode. A question and answer session will follow the formal presentation.
Operator: Welcome to the Streamline Health Solutions Incorporated fourth quarter and fiscal year 2024 earnings conference call. At this time, all participants are in the listen only mode.
Operator: A question and answer session will follow the formal presentation. If anyone should require operator assistance, please press star zero on your telephone keypad. As a reminder, this conference is being recorded.
Speaker Change: If anyone should require operator assistance. Please press star zero on your thoughts on keypad. As a reminder, this conference is being recorded it is now my pleasure to introduce Jacob Goldberger of Vice President of Finance. Thank you you may begin.
Operator: It is now my pleasure to introduce Jacob Goldberger, Vice President of Finance. Thank you. You may begin.
Jacob Goldberger: Thank you for joining us for the Corporate Update and Financial Results Review of Streamline Health Solutions for the 12 and three months ended January 31st, 2025. As the conference call operator indicated, my name is Jacob Goldberger.
Thank you for joining us for the corporate update and financial results review of streamline health solutions for the 12 and three months ended January 31 2025.
Speaker Change: As conference call Operator indicated my name is Jacob Goldberger, joining me on the call today are Ben still President and Chief Executive Officer, and B, J Reeves Chief Financial Officer.
Jacob Goldberger: Joining me on the call today are Ben Stilwill, President and Chief Executive Officer, and B.J. Reeves, Chief Financial Officer.
Jacob Goldberger: At the conclusion of today's prayer remarks, we will open the call for a question and answer session. If anyone participating on today's call does not have a full-text copy of our press release announcing these results, you can retrieve it from the company's website at www.streamlinehealth.net or from numerous financial websites.
Speaker Change: Conclusion of today's prepared remarks, we will open the call for a question and answer session. If anyone participating on today's call does not have a full text copy of our press release announcing these results you can retrieve it from the Companys website at Www dot streamlined helped on that or from numerous financial websites.
Jacob Goldberger: Before we begin with prepared remarks, we want to be sure we are clear for everyone on the record how certain information, which may be provided today, as with all of our earnings calls, should be viewed. We therefore submit for the record the following statement. Statements made on this conference call that are not historical facts are considered to be forward-looking statements within the meaning of the Private Securities Delegation Reform Act of 1995. These are subject to risks, uncertainties, assumptions, and other factors that could cause actual results to differ materially from those we may discuss.
Speaker Change: Before we begin with prepared remarks, you want to be sure. We are clear for everyone on the record how certain information, which maybe provided today as with all of our earnings calls should be viewed we therefore submit for the record. The following statement statements made on this conference call that are not historical facts are considered before looking statements within the meaning of the private Securities Litigation Reform Act of 90 95.
Speaker Change: Subject to risks uncertainties assumptions and other factors that could cause actual results to differ materially from those who may discuss.
Jacob Goldberger: Please refer to the company's press releases and filings made with the US Securities and Exchange Commission, including our most recent Form 10-K annual report, which is on file with the SEC for more information about these risks, uncertainties, and assumptions and other factors. As always, we are presenting management's current analysis of these items as of today. Participants on this call should take into account these risks when evaluating the topics we will discuss. Please note, Streamline is not undertaking any commitment or obligation to publicly revise any such forward-looking statements made today.
Speaker Change: Please refer to the company's press releases and filings made with the U S Securities and Exchange Commission, including our most recent Form 10-K annual report, which is on file with the SEC for information about these risks uncertainties and assumptions and other factors as always we are presenting management's current analysis of these items as of today.
Speaker Change: Participants on this call should take into account these risks when evaluating the topics. We will discuss please note streamline is not undertaking any commitment or obligation publicly revise any such forward looking statements made today.
Jacob Goldberger: On today's call, we will discuss non-GAAP financial measures such as adjusted EBITDA and booked SAS ACV. Management uses these measures to help provide better insight into our financial performance. However, certain items of income and expense are not included in these measures, so these calculations may differ from those which another entity may utilize in calculating their own non-GAAP measures.
Speaker Change: Today's call, we will discuss non-GAAP financial measures such as adjusted EBITDA and book SaaS ACB management uses these measures to help provide better insight into our financial performance. However, certain items of income and expense are not included in these measures. So these calculations may differ from those which another entity may utilize in calculating their own non-GAAP measures.
Jacob Goldberger: To help you compare these amounts on consistent terms, please refer to our website at www.streamlinehealth.net and our earnings release for reconciliation of such non-GAP measures to the most comparable GAP measure.
Speaker Change: So if you compare these amounts that consistent terms. Please refer to our website at www Dot streamline health net and our earnings release for a reconciliation of such non-GAAP measures to the most comparable GAAP measures.
Benjamin Stilwill: I would now like to turn the call over to Ben Stilwill, CEO. Thanks, Jacob. And thank you all for joining this morning. In fiscal 2024, we furthered our mission to ensure our health system clients be paid accurately for the care they've provided. As of January 31, 2025, our solutions are delivering an annualized financial impact of more than $210 million across our client base. That impact is the result of our partnership with revenue cycle departments who leverage our solutions to maintain control over the financial outcomes of their health system. And thanks to our solutions, our team, and our client partnerships, U.S.
Ben: I would now like to turn the call over to Ben still CEO.
Ben: Thanks, Jacob and thank you all for joining this morning.
Ben: In fiscal 2024, we furthered our mission to ensure our health system clients be paid accurately for the care they provide it as.
Ben: As of January 31, 2025, our solutions are delivering an annualized financial impact of more than $210 million across our client base.
Ben: That impact is the result of our partnership with revenue cycle Department to leverage our solutions to maintain control over the financial outcomes of their health systems.
Ben: And thanks to our solutions, our team and our client partnerships U S health systems, now have $210 million to care for their communities in 2025.
Benjamin Stilwill: health systems now have $210 million to care for their communities in 2025.
Benjamin Stilwill: As of the end of fiscal 2024, we had booked SAS ACV of $14 million, and as of April 30, 2025, booked SAS ACV totaled $14.6 million, $13.1 million of which was implemented. Since we last reported our October 31, 2024 results, we booked an additional $1.4 million in new SAS ACV. And this was offset by $700,000 of churn, the majority of which was the result of two clients lost to an acquisition of those health systems. $350,000 of our new bookings were the result of our Oracle channel for RevID, including a new Community Works client. And we expect continued wins from this channel as our relationship with Oracle remains strong.
Ben: As of the end of fiscal 2024, we had booked SaaS ACB, a $14 million and as of April 32025 book SaaS ACB totaled $14 6 million $13 1 million of which was implemented.
Ben: Since we last reported our October 31, 2024 results, we booked an additional one $4 million and new SaaS ACB.
Ben: And this was offset by $700000 of churn the majority of which was the result of two clients lost to an acquisition of those health systems.
Ben: $350000 of our new bookings were the result of our Oracle channel for <unk>, including a new community works clients.
Ben: And we expect continued wins from this channel as our relationship with Oracle remains strong.
Benjamin Stilwill: The remaining new bookings represent significant new evaluator clients, which were sold through our direct channel and influenced by their peers and our talented sales team.
Ben: The remaining new bookings represent significant new evaluator clients, which were sold through our direct channel and influenced by their peers and our talented sales team.
Benjamin Stilwill: We recently made the proactive decision to discontinue selling our quality module as an independent unit. While the module reflected an interesting market opportunity, it did not meet our bookings expectation, and the call point was too distinct from Evaluator and RevID. So rather than invest further in a solution that would not deliver the returns we demand, we chose to redirect resources to initiatives that allow us to expand the impact of our solution's core value proposition. So in particular, we have focused on our resources towards denial prevention functionality.
Ben: We recently made the proactive decision to discontinue selling our quality model as an independent unit.
Ben: While the module reflected an interesting market opportunity it did not meet our bookings expectation and the call point with two distinct from evaluated and RFID, so rather than invest further in solution that will not deliver the returns we demand we chose to redirect resources to initiatives that allow us to expand the impact of our solutions core value proposition so in <unk>.
Ben: Particular, we are focused on our resources towards denial prevention functionality.
Benjamin Stilwill: So speaking of, as of last night, we're excited to debut our new denial prevention functionality within the evaluator platform, a major step forward in how we help clients protect revenue in real time. These new rules will enable evaluator users to proactively identify and prevent both outright denials and coding DRG downgrades before a claim is submitted. This capability is the result of a deep collaboration across our rules team, client partners, and our data science efforts, incorporating the insights from client feedback and machine learning trained on 835 remittance data we've received from select users. By leveraging real-world denial patterns, we've built rules that are not only clinically sound, but directly aligned with payer behavior.
Ben: So speaking up as of last night, we're excited to debut our new denial prevention functionality within the evaluated platform a major step forward and how we help clients protect revenue and real time. These.
Ben: These new rules will enable evaluate or users to proactively identify and prevent both outright denials and coding DRG downgrades before a claim is submitted.
Ben: This capability as a result of the deep collaboration across our rules team client partners and our data science efforts incorporating the insights from client feedback and machine learning train an 835 remittance data we've received from select users.
Ben: By leveraging real world denial patterns, we built rules that are not only clinically sound book directly aligned with payer behavior.
Benjamin Stilwill: And based on extensive backtesting, we expect these new rules to expand the inpatient financial impact of evaluator by more than 15% and potentially double the financial impact on outpatient cases. That's particularly important given the surge in denial activity we're seeing across the industry the last couple of years, especially from the commercial payers, which tend to represent higher dollar patient populations for our clients. These denials are placing an unsustainable burden on providers, and we believe our denial prevention functionality is launching at exactly the right time to provide much-needed relief and measurable value. Our client success team has been sharing this new functionality with our clients over the last couple months, and they are universally excited.
Ben: And based on extensive testing and we expect these new rules to expand the inpatient financial impact of evaluated by more than 15% and potentially double the financial impact on outpatient cases.
Ben: That's particularly important given the surge in denial activity, we're seeing across the industry. The last couple of years, especially from commercial payers, which tend to represent higher dollar patient populations for our clients.
Ben: These denials are placing an unsustainable burden on providers and we believe our denial prevention functionality is launching at exactly the right time to provide much needed relief and measurable value.
Ben: Our client success team has been sharing this new functionality for our clients over the last couple of months and their universally excited and we'll be quickly translating those client results into a data story and narrative to arm our direct sellers.
Benjamin Stilwill: And we'll be quickly translating those client results into a data story and narrative to Armour direct sellers. Our Rev-ID clients are more excited than ever to talk about their partnerships with Streamline. Last week, one of our Rev-ID users, Crisp Regional, presented to a packed room at a user conference how they leveraged our solution to develop a charge reconciliation program and the impact of adding this tool and workflow to their revenue cycle. Many of these community works type systems have not historically had the resources to attack charge capture, but many sorely need it. And as I've noted, we had a successful new booking from community works user recently and have been receiving significant inbound interest from that cohort.
Ben: Our <unk> clients are more excited than ever to talk about their partnerships with streamline last week, one of our <unk> users Chris Regional Rep.
Chris: Presented to a packed room at the user conference how they leveraged our solution to develop a charge reconciliation program and the impact of adding this tool and workflow to their revenue cycle.
Chris: Many of these community works type systems have not historically had the resources to attack charge capture but many sorely needed and as I've noted we had a successful new booking for key.
Chris: User recently and have been receiving significant inbound interest from that cohort.
Benjamin Stilwill: We're leaning into those user stories in a bigger way with webinars and finding ways to encourage further peer-to-peer marketing from our clients. We expect the enhanced value offered by new features like denials prevention and improving client referenceability to translate to an increased rate of bookings in fiscal 2020. Our implementation teams continue to make strides in their ability to execute projects across both solutions. Our most recent evaluator, Go Live, was completed 42 days after contract signature, and our most recent client, WIM, wants to go live by July 1st. We expect to maintain this rapid pace on the evaluator side, and our RevID implementation time continues to accelerate.
Chris: We're leaning into those user stories in a bigger way with Webinars and finding ways to encourage further peer to peer marketing from our clients.
Chris: We expect to enhance value offered by new features like denial prevention and improving client refresh.
Chris: Ability to translate to an increased rate of bookings in fiscal 'twenty five.
Chris: Our implementation teams continue to make strides in our ability to execute projects across both solutions are most recent go live was completed 42 days.
Chris: After contract signature and our most recent client win once they go live by July one.
Chris: We expect to maintain this rapid pace on the evaluate aside and a rug IV implementation time continues to accelerate.
Benjamin Stilwill: Our new future push, pipeline, and improved implementation execution mean we maintain our expectation related to achieving an EBITDA profitable run rate as we exit the second quarter of fiscal 2025.
Chris: Our new future push pipeline and improved implementation execution, we maintain our expectation related to achieving an EBITDA profitable run rate as we exited the second quarter of fiscal 2025.
Benjamin Stilwill: Healthcare systems need to be able to succeed in the revenue cycle so that they can get paid for the care they provide. We believe it is our duty to develop the products and provide the insights so they can succeed.
Chris: Health care systems need to be able to succeed in the revenue cycle. So that they can get paid for the care. They provide we believe it is our duty to develop the products and provide the insights so they can succeed.
B.J. Reeves: With that, I'd like to turn the call over to our CFO, B.J. Reeves. Thanks, Ben. As Ben mentioned, our booked SAS ACV, as of January 31, 2025, totaled $14 million, and as of April 30, 2025, totaled $14.6 million. Currently, $13.1 million of our booked SAS ACV is implemented, and we anticipate we successfully implement and achieve an EBITDA profitable ARR run rate during the first half of fiscal 2025.
Speaker Change: With that I'd like to turn the call over to our CFO BJ ribs P.
Speaker Change: P J.
Speaker Change: Thanks Ben.
Speaker Change: As Ben mentioned, our booked SaaS ACB as of January 31, 2025 totaled $14 million and as of April 32025, total $14.6 million.
Speaker Change: Lee $13 $1 million about booked SaaS H D. D. It's implemented and we anticipate we successfully implement and achieve an EBITDA profitable run rate during the first half of fiscal 2025.
B.J. Reeves: The total revenue for the fourth quarter of fiscal 2024 was $4.7 million, as compared to $5.4 million during the fourth quarter of fiscal 2023. For the 12 months ended January 31, 2025, revenue totaled $17.9 million, as compared to $22.6 million during fiscal 2024. The change in total revenue is attributable to previously announced SAS non-renewals as well as lower revenue from the company's legacy maintenance and support contracts and professional service offerings, offset by new bookings and go-lives in the company's SAS business. SAS revenue for the fourth quarter of fiscal 2024 totaled $3.1 million, 66% of total revenue, compared to SAS revenue of $3.4 million, or 64% of total revenue during the fourth quarter of fiscal 2023.
Speaker Change: Total revenue for the fourth quarter of fiscal 2024 was $4 7 million.
Speaker Change: As compared to $5 $4 million during the fourth quarter of fiscal 2023 for.
Speaker Change: For the 12 months ended January 31, 2025 revenue totaled $17 $9 million as compared to $22 $6 million during fiscal 2024.
Speaker Change: Yes.
Speaker Change: The change in total revenue was attributable to previously announced SaaS nonrenewals as well as lower revenue from the company's legacy maintenance and support contracts and professional service offerings offset by new bookings and go lives in the company SaaS business.
Speaker Change: SaaS revenue for the fourth quarter of fiscal 2024 totaled $3 1 million, 66% of total revenue compared to SaaS revenue of $3 $4 million or 64% of total revenue during the fourth quarter of fiscal 2023.
B.J. Reeves: For the 12 months ending January 31, 2025, SAS revenue totaled $11.8 million, or 66% of total revenue, compared to $14.1 million, or 62% of total revenue, during fiscal 2023. As previously reported, the company had a SAS contract which did not renew at the end of its 2023 fiscal year. Net loss for the fourth quarter of fiscal 2024 was $2.1 million compared to net loss of $1.4 million during the fourth quarter of fiscal 2023. Fiscal 2024's net loss totaled $10.2 million compared to a net loss of $18.7 million during fiscal 2023. The increased net loss during the fourth quarter was the result of the lower total revenue and higher non-cash interest expense offset by lower total operating expenses as compared to the fourth quarter of fiscal 2023.
Speaker Change: For the 12 months ending January 31, 2025, SaaS revenue totaled $11 $8 million or 66% of total revenue compared to $14 $1 million or 62% of total revenue during fiscal 2023.
Speaker Change: As previously reported the company had a SaaS contract, which did not renew at the end of 2023 fiscal years.
Speaker Change: Net loss for the fourth quarter of fiscal 2024 was $2 $1 million compared to net loss of $1 $4 million during the fourth quarter of fiscal 2023.
Speaker Change: Fiscal 2024, net loss totaled $10 $2 million compared to a net loss of $18 $7 million during fiscal 2023.
Speaker Change: The increased net loss during the fourth quarter was the result of the lower total revenue and iron noncash interest expense offset by lower total operating expenses as compared to the fourth quarter of fiscal 2023.
B.J. Reeves: The improved net loss in fiscal year 2024 was the result of $10.8 million of non-cash impairment charges incurred during fiscal year 2023 that did not recur in the current fiscal year.
Speaker Change: The improved net loss in fiscal year 2024 was the result of $10 $8 million of noncash impairment charges incurred during fiscal year 2023 that did not recur in the current fiscal year.
B.J. Reeves: Cash and cash equivalents as of January 31, 2025 were $2.2 million as compared to $3.2 million as of January 31, 2024. The company had a $1 million outstanding balance on its revolving credit facility as of January 31, 2025, compared to $1.5 million as of January 31, 2024.
Speaker Change: Cash and cash equivalents as of January 31, 2025, or $2 $2 million as compared to $3 2 million as of January 31 2024.
Speaker Change: The company had a $1 million outstanding balance on its revolving credit facility as of January 31, 2025, compared to $1.5 million as of January 31, 2024.
B.J. Reeves: Subsequent to the end of the fiscal period on March 28, 2025, the company and its principal lender amended certain financial covenants related to the company's senior term line and revolving line of credit, which are described in more detail in the company's annual report on Form 10-K for the fiscal year ended January 31, 2025. On March 28, 2025, the company drew an additional $1 million from its revolving line of credit.
Speaker Change: Subsequent to the end of the fiscal period of March 28, 2025, the company and its principal lender amended certain financial covenants related to the company's senior term loan and revolving line of credit which are described in more detail in the company's annual report on Form 10-K for the fiscal year ended January 31 2025.
Speaker Change: On March 28, 2025, the company drew an additional $1 billion summit's revolving line of credit.
B.J. Reeves: And that concludes our prepared remarks.
Speaker Change: And that concludes our prepared remarks operator, please begin the question and answer session.
Operator: Operator, please begin the question and answer session. Thank you.
Speaker Change: Thank you if he would like to ask a question. Please press star one on your telephone keypad, a confirmation tone will indicate your line is in the question queue. You May press star two if he would like to remove your question from the queue and for participants using speaker equipment may be necessary to pick up your handset before pressing the star keys.
Operator: If you would like to ask a question, please press star 1 on your telephone keypad. A confirmation tone will indicate your line is in the question area. You may press star 2 if you would like to remove your question from the queue.
Operator: And for participants using speaker equipment, it may be necessary to pick up your handset before pressing the star 2.
Speaker Change: <unk>.
Neil Cataldi: Our first question is from Neil Cataldi with Blueprint Capital Management. Hey Ben, thanks for taking a few of my questions today. I'll start with denials. Yeah, I'll start with denials prevention. Sounds like this is, you know, ready to go in terms of your ability to sell the product. Can you talk a little bit about what that means for the current customer base and how does it play into the marketability of Evaluator? Yeah, sure. Great question. So we learned a lot from from the quality module that we had debuted last year and try to lean more into where clients could find value out of the core functionality of evaluator.
Neil Cataldi: Our first question is from Neil Cataldi with Blueprint capital management. Please proceed.
Neil Cataldi: Hey, Dan Thanks for taking my questions today.
Speaker Change: Yeah, Hey, Nick I'll start with denials for yeah, I'll start with denials prevention. It sounds like this is you know ready to go in terms of your ability to sell the product can you talk a little bit about what that means for the current customer base and how does it play into.
Neil Cataldi: The marketability of evaluate or.
Neil Cataldi: Yeah.
Neil Cataldi: Yes sure Great question. So we learned a lot from from the quality module that we had.
Neil Cataldi: Debuted last year and tried to lean more into where clients could find value out of the core functionality of a value and we've been on this the stick of trying to have our clients are.
Benjamin Stilwill: We've been on this the shtick of trying to have our clients get things right the first time pre-bill before the bill goes out the door. And this really, you know, denials is the ultimate, you know, the final whatever the payer did with the provider. If we can get those signals into the pre-bill workflow, it's immensely helpful to make sure that the claim is bulletproof by the time that it leaves the health system and goes to the payer. So it's hugely valuable. It's something that our clients are super excited about.
Neil Cataldi: Get things right. The first time pre bill before the Bill goes out the door and there's really no denials as the ultimate.
Neil Cataldi: The final whatever the payer did with the provider if we can get those signals into the pre bill workflow is immensely helpful to make sure that the.
Neil Cataldi: The claim is bullet proof by the time that it leaves the health system and goes to the parents. So it's usually valuable it's it's something that our clients are super excited about and we did a lot of hands on showing declines what we were doing and getting their feedback along the way.
Benjamin Stilwill: And we did a lot of hands on showing the clients what we were doing and getting their feedback along the way. Okay, so maybe for those new to the story, you built a product, you rolled it out last year, you had some people use it, test it, the data's come back, it's been really good, and now there's a bit of a focus to push it forward. Yeah, exactly. So now we're able to quantify what we're actually impacting as far as preventing denials. And it was done, you know, talking to our clients around how they viewed denial prevention and the coding cycle and everything like that.
Neil Cataldi: Yeah.
Neil Cataldi: Okay.
Neil Cataldi: Okay. So maybe for those new to the story you built the product you you rolled it out last year you had some people use it task that the data has come back that could really good and and now there's a bit of a focus to keep pushing forward.
Neil Cataldi: Yeah exactly so so now we're able to quantify what we're actually impacting as far as preventing denials.
Neil Cataldi: It was done you know talking to our clients around how they viewed denial prevention in the coding cycle and everything like that and so now they're able to go to their executives and say this is what my actual coding function as is doing as far as preventing this huge denial problem that the industry is having.
Benjamin Stilwill: And so now they're able to go to their executives and say, this is what my actual coding function is, is doing as far as preventing this huge denial problem that that the industry is having.
Benjamin Stilwill: Okay, great. You mentioned implementation timelines, 42 days. I think you said on the evaluator implementation, that sounds like it's really improved. And so I was wondering what changed? What are you guys doing to enable these quicker implementations? Is it a one-off, or are we sort of resetting the expectation on how quick you guys can go a little bit faster now? Yeah, I think 42 days is still less than the average, certainly less than our financial forecast, but it is obviously a good example. But we've significantly dropped our overall average time. So a couple years ago, we were talking about four to six months for an evaluator implementation.
Neil Cataldi: Okay. Great you rent you mentioned implementation timelines are 42 days I think you said on the valley evaluate our implementation that that that sounds like it's.
Neil Cataldi: Really improved and so I was wondering what changed what are you guys doing to enable these quicker implementation is it a one off or are we sort of you know resetting that the expectation on how quickly you guys can go a little bit faster now.
Neil Cataldi: Yeah, I think 42 days is still.
Neil Cataldi: Less than the average certainly lessen our financial forecast, but it is obviously a good example, but we've significantly dropped our overall average time. So a couple of years ago, we were talking about a four to six months for and evaluate our implementation most of them are getting done in two maybe three months or less obviously than this.
Benjamin Stilwill: Most of them are getting done in two, maybe three months or less, obviously, in this case. And then we learned a lot doing that standardizing data, standardizing training, making sure that people have the ability to have success on day one. And I think that probably the most important part is on the RevID side of things, it's a little bit more complicated of an implementation. When we first acquired the solution, it was upwards of nine months to a year of implementation. And that's dropping dramatically with each implementation we're doing based on taking the evaluator playbook into RevID.
Neil Cataldi: Case.
Neil Cataldi: And then where we learned a lot doing that standardizing data standardizing training, making sure that people have the ability to have success on day, one and I think that probably the most important part is on the <unk> side of things, it's a little bit more complicated of an implementation. When we first acquired the solution. It was upwards of nine months to a year of implement.
Neil Cataldi: Patient and that's dropping dramatically with with each implementation, we're doing based on taking the evaluate a playbook into <unk>. So I think we'll see that number also significantly reduce.
Benjamin Stilwill: So I think we'll see that number also significantly reduce. Okay.
Neil Cataldi: Okay, and my last one I.
Benjamin Stilwill: And my last one, I know you guys have made a lot of changes to the sales force over the past year. It's been a little, I don't know, quiet, I guess, with bookings, you know, the start of this year. What gives you guys confidence that, you know, there's some momentum building in the pipeline and that we'll see stronger bookings going forward? Yeah, I think we're really trying to lean into our clients, the current client journeys that people have been successful with. So trying to put, whether it was last week where we had a Rev ID user at the Oracle conference or having webinars with our clients, speaking live with prospects and current clients, we're really trying to celebrate those victories so that when the salesperson does pick up the phone, it's much more likely that they will say, yeah, that's a club I that's an organization I want to be involved with.
Neil Cataldi: I know you guys have made a lot of changes to the sales force over the past year, a it's been a little.
Neil Cataldi: I dunno quiet I guess with with with booking.
Neil Cataldi: The start of this year, what gives you guys confidence that yeah. There's good there's some momentum building in the pipeline in that and that we'll see stronger bookings going forward.
Neil Cataldi: Yeah, I think we're really trying to lean into our clients.
Neil Cataldi: The current client journeys that people have been successful at so trying to put whether it was last week, where we had a rough idea user at the at the Oracle conference or having webinars with our clients speaking live with prospects and current clients. We're really trying to celebrate those victories. So that when the salesperson does pick up the phone it's much more likely that they.
Neil Cataldi: I will say, yes, that's a that's a club I want to be part of that is that's our organization I want to be involved with.
Benjamin Stilwill: And we've seen a lot of top of funnel activity as a result of having our clients really be the focus as opposed to purely just us showing up at a trade show or what have you. So I think we'll, you know, we've seen some activity recently. I mean, I don't want to oversell the Oracle conference we were just at, but a lot of a lot of activity there and the webinars and starting to get things that are more moving on the on the top of the funnel.
Neil Cataldi: We've seen a lot of top of funnel activity as a result of having our clients really be the focus as opposed to purely just us showing up at a trade show or what have you.
So I think well you know we've seen some activity recently I mean, I don't want to oversell. The the Oracle conference for you does that but a lot of a lot of activity there in the webinars and starting to get things that are more moving on the on the top of the funnel.
Neil Cataldi: Yeah.
Benjamin Stilwill: Okay, great. Look forward to seeing the progress. Thanks, guys. Thanks, Stu.
Neil Cataldi: Okay, Great look forward to seeing the progress thanks guys.
Neil Cataldi: Thanks Neil.
Neil Cataldi: Okay.
Operator: We have reached the end of our question and answer session.
Speaker Change: We have reached the end of our question and answer session I would like to turn the conference back over for closing remarks.
Operator: I would like to turn the conference back over for closing remarks. Thank you all for your support of Streamline Health. We look forward to speaking with you all again when we report our first quarter 2025 results.
Speaker Change: Thank you all for your support of streamline health, we look forward to speaking with you all again, when we report our first quarter 2025 results.
Operator: Thank you.
Speaker Change: Thank you. The spectra include today's conference you may disconnect. Your lines at this time and thank you for your participation.
Operator: This will conclude today's conference.
Operator: You may disconnect your lines at this time and thank you for your participation.
Speaker Change: [music].
Speaker Change: Yeah.
Speaker Change: Yeah.
Speaker Change: Uh huh.
Speaker Change: [music].
Speaker Change: Okay.
Speaker Change: Yeah.
Speaker Change: [music].
Speaker Change: Yeah.
Speaker Change: [music].
Speaker Change:
Speaker Change: Yes.
Yes.
Speaker Change: Yeah.
Speaker Change: [music].
Operator: END © The Bulletproof Executive 2013 © BF-WATCH TV 2021 Closing Music
Speaker Change: Yes.
Speaker Change: Okay.
Speaker Change: Yeah.
Speaker Change: [music].
Speaker Change: Okay.
Speaker Change: Okay.
Speaker Change: Yeah.
Speaker Change: Okay.
Speaker Change: [music].
Speaker Change: Yes.
Speaker Change: [music].
Speaker Change: Right.